Skip to content

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins (Phenol and P-Cresol ) in Hemodialysis Patients: A Double Blind Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03527680
Enrollment
42
Registered
2018-05-17
Start date
2016-09-01
Completion date
2016-12-30
Last updated
2018-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis Complication

Brief summary

Uremic toxins such as p-cresol and phenol are suggested to be associated with higher mortality in hemodialysis patients. The aim of this study was to investigate the effects of probiotics on serum p-cresol level in hemodialysis patients.

Detailed description

Overall, 42 hemodialysis patients (10 women and 32 men) were divided randomly into the Lactobacillus rhamnosus group (21 patients) and the placebo group (21 patients).

Interventions

DIETARY_SUPPLEMENTLactobacillus rhamnosus

daily one capsule containing 1.6\*107 CFU of Lactobacillus Rhamnosus prepared by Tabriz Nutrition Research Center from yogurt and cheese of different farms located in the suburbs Heris, after meal for 28 days

daily one capsule of placebo

Sponsors

nooshin dalili
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Age more than 20 years * Acceptable performance of alimentary system * Ability to drink at least 200 ml of water per day * No history of being allergic to fungi and yeast * Absence of acute medical illness * life expectancy more than 3 months * Accept and sign the consent

Exclusion criteria

* Patient's unwillingness to participate in the study * History of smoking, peritoneal dialysis (PD) or previous kidney transplantation * Lactation or pregnancy * Drug history including antibiotics, prebiotics, probiotics, herbal drugs, psychedelic drugs, flavors.

Design outcomes

Primary

MeasureTime frame
pre- and post-treatment p-cresol levels4 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026